跳至主要内容
临床试验/IRCT20100706004329N9
IRCT20100706004329N9招募中3 期

Comparison of metformin and placebo on breast mammography density in healthy women over 40 years

Tehran University of Medical Sciences0 个研究点目标入组 146 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
146

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40 years 至 no limit(—)
性别
Female

入选标准

  • Female gender
  • Age over 40 years

排除标准

  • Suspicion of malignancy
  • Used of drugs that affect metabolic status, such as weight, glucose, and lipid-lowering agents During the study or three months before the study
  • History of breast cancer
  • Proven or suspected pregnancy and lactation during the intervention
  • Other medical conditions, such as cardiovascular disease, epilepsy, renal or hepatic disorders
  • Contraindications for metformin use (such as hypersensitivity to biguanides, acidemia, heart disease, alcohol consumption, gastroparesis, hepatic disease, hyperthyroidism or hypothyroidism, severe iron deficiency anemia, renal impairments)
  • History of unwanted and intolerable side effects of metformin (such as abdominal pain, chest pain, chills, cholestasis, diarrhea, dizziness, increased liver enzymes, severe headache, hepatitis, hypoglycemia, megaloblastic anemia, myalgia, nausea, Palpitations, rash, rash, vomiting)
  • Suffering from hormonal disorders and metabolic diseases such as hypo or hyperthyroidism, metabolic syndrome, diabetes, severe hyperlipidemia, galactorrhea

研究者

相似试验

The effect of metformin on breast density | 临床试验